The Upcoming PCAC Meeting The FDA notice confirms that the PCAC will convene this summer to evaluate whether to recommend the following seven bulk drug substances for inclusion on the 503A bulks list: July 23, 2026: BPC-157 (free base / acetate) KPV (free base / acetate) Thymosin Beta-4, Fragment (LKKTETQ) (TB-500) (free base / acetate) MOTs-C (free base / acetate) July 24, 2026: Emideltide (DSIP) (free base / acetate) Semax (free base / acetate) Epitalon (free base / acetate) All seven substances are of considerable interest to compounding pharmacies, prescribers, and patients
If this happens, you need to get medical help right away and stop using any glutathione supplements or treatments
Conner Mertens 05:31 And one of the hot topics during COVID
[DOI] [PMC free article] [PubMed] [Google Scholar] 281.Cicerale S., Lucas L., Keast R
Streppel MT, Arends LR, van t Veer P, Grobbee DE, Geleijnse JM
Usually resolves within 1-2 weeks